1. Home
  2.  » 
  3. Events
  4.  » ASCO Explained

ASCO Explained

ASCO Preview: What to watch for

Date: Wednesday, May 27
Time: 3:00pm ET / 12:00pm PT

As we head into the American Society of Clinical Oncology (ASCO) weekend, cancer experts will highlight closely watched data sets to be unveiled at the virtual meeting–and discuss how they could change prescribing patterns. This discussion will take a close look at oncology’s hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference’s most highly anticipated studies, 2020’s biggest research trends, and the data they’re most looking forward to seeing.

Click here to register for the event. 

ASCO Postview: Highlights from the virtual conference

Date: Monday, June 1
Time: 3:00pm ET / 12:00pm PT

Experts and executives will break down the biggest data that came out during the ASCO virtual conference, as well as the implications they could have for prescribers, patients and drug makers. This panel discussion will feature data in a range of tumor types, including lung, bladder and colorectal. Find out which results will change clinical practice, set up market-share battles and position drugs for big new indications.

Click here to register for the event.

 

Featured Speakers:

Roy D. Baynes, MD, PhD
Senior Vice President, Global Clinical Development, and Chief Medical Officer
Merck Research Laboratories

Andrew Berens, MD
Managing Director, Targeted Oncology
SVB Leerink

Chris Boshoff, MD, PhD, FMedSci
Senior Vice President & Chief Development Officer, Oncology
Pfizer Global Product Development

Daina Graybosch, PhD
Managing Director, Immuno-Oncology
SVB Leerink

Jennifer Keating Litton, MD
Vice President ad interim of Clinical Research
The University of Texas MD Anderson Cancer Center

Vanessa M. Lucey, PhD, MBA
Director
CRI Venture Fund and Clinical Accelerator

Mike Riley
Region President, Biologics – North America
Catalent